BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27138871)

  • 21. Predictors of thrombus burden and no-reflow of infarct-related artery in patients with ST-segment elevation myocardial infarction: importance of platelet indices.
    Cakici M; Cetin M; Balli M; Akturk E; Dogan A; Oylumlu M; Abus S; Yildiz E; Sungur A; Celiker M
    Blood Coagul Fibrinolysis; 2014 Oct; 25(7):709-15. PubMed ID: 24806326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention.
    Ugur M; Gul M; Bozbay M; Cicek G; Uyarel H; Koroglu B; Uluganyan M; Aslan S; Tusun E; Surgit O; Akkaya E; Eren M
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):806-11. PubMed ID: 24911455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet to Lymphocyte Ratio as a Prognostic Marker of In-Hospital and Long-Term Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction.
    Ozcan Cetin EH; Cetin MS; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
    Angiology; 2016 Apr; 67(4):336-45. PubMed ID: 26101368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çiçek G; Açıkgoz SK; Bozbay M; Altay S; Uğur M; Uluganyan M; Uyarel H
    Angiology; 2015 May; 66(5):441-7. PubMed ID: 24834932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent.
    Cho KI; Ann SH; Singh GB; Her AY; Shin ES
    PLoS One; 2015; 10(7):e0133934. PubMed ID: 26207383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Murat SN; Ergun G; Duran M; Kasapkara HA; Demircelik MB; Cetin M; Ocek AH
    Am J Cardiol; 2014 Aug; 114(3):342-7. PubMed ID: 24948493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the Relationship Between Inflammatory Markers and Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome After Coronary Angiography.
    Zorlu C; Koseoglu C
    Angiology; 2020 Mar; 71(3):249-255. PubMed ID: 31808357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White blood cell count to mean platelet volume ratio: A novel and promising prognostic marker for ST-segment elevation myocardial infarction.
    Çiçek G; Açıkgöz SK; Yayla Ç; Kundi H; İleri M
    Cardiol J; 2016; 23(3):225-35. PubMed ID: 26779969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet to Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Sun XP; Li J; Zhu WW; Li DB; Chen H; Li HW; Chen WM; Hua Q
    Angiology; 2018 Jan; 69(1):71-78. PubMed ID: 28464698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Estévez-Loureiro R; Salgado-Fernández J; Marzoa-Rivas R; Barge-Caballero E; Pérez-Pérez A; Noriega-Concepción V; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A; Kaski JC
    Thromb Res; 2009 Nov; 124(5):536-40. PubMed ID: 19467699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction.
    Sawant AC; Adhikari P; Narra SR; Srivatsa SS; Mills PK; Srivatsa SS
    Cardiol J; 2014; 21(5):500-8. PubMed ID: 24142685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mean Platelet Volume to Lymphocyte Ratio as a Novel Marker for Diabetic Nephropathy.
    Kocak MZ; Aktas G; Erkus E; Duman TT; Atak BM; Savli H
    J Coll Physicians Surg Pak; 2018 Nov; 28(11):844-847. PubMed ID: 30369376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of mean platelet volume to platelet count ratio in older patients with non-ST elevation acute coronary syndrome receiving primary percutaneous coronary intervention: a retrospective study.
    Sun X; Li H; Zhang Y; He F; Lu C
    Minerva Cardioangiol; 2019 Apr; 67(2):102-108. PubMed ID: 30621371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Rechciński T; Jasińska A; Foryś J; Krzemińska-Pakuła M; Wierzbowska-Drabik K; Plewka M; Peruga JZ; Kasprzak JD
    Cardiol J; 2013; 20(5):491-8. PubMed ID: 24469872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Predictive role of Neutrophil-to-Lymphocyte Ratio (NLR) and Mean Platelet Volume-to-Lymphocyte Ratio (MPVLR) for Cardiovascular Events in Adult Patients with Acute Heart Failure.
    Angkananard T; Inthanoo T; Sricholwattana S; Rattanajaruskul N; Wongsoasu A; Roongsangmanoon W
    Mediators Inflamm; 2021; 2021():6889733. PubMed ID: 34671226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention.
    Jiang P; Song Y; Xu JJ; Wang HH; Jiang L; Zhao W; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Cardiol J; 2019; 26(2):138-146. PubMed ID: 30009376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.
    Toprak C; Tabakci MM; Simsek Z; Arslantas U; Durmus HI; Ocal L; Demirel M; Ozturkeri B; Ozal E; Kargin R
    Postepy Kardiol Interwencyjnej; 2015; 11(4):288-97. PubMed ID: 26677378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.
    Karahan Z; Uçaman B; Uluğ AV; Aydınalp Ö; Uğurlu M; Çevik K; Kaya İ; Öztürk Ö
    Angiology; 2016 Feb; 67(2):151-6. PubMed ID: 26007233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation.
    Hudzik B; Szkodziński J; Hawranek M; Lekston A; Poloński L; Gąsior M
    Acta Diabetol; 2016 Oct; 53(5):807-15. PubMed ID: 27339195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.